Page last updated: 2024-09-03

23-seleno-25-homotaurocholic acid and epirubicin

23-seleno-25-homotaurocholic acid has been researched along with epirubicin in 1 studies

Compound Research Comparison

Studies
(23-seleno-25-homotaurocholic acid)
Trials
(23-seleno-25-homotaurocholic acid)
Recent Studies (post-2010)
(23-seleno-25-homotaurocholic acid)
Studies
(epirubicin)
Trials
(epirubicin)
Recent Studies (post-2010) (epirubicin)
1478425,4531,8381,570

Protein Interaction Comparison

ProteinTaxonomy23-seleno-25-homotaurocholic acid (IC50)epirubicin (IC50)
Genome polyprotein 0.75
Tyrosine-protein kinase FynHomo sapiens (human)5.181

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, PR; Cuschieri, A; Hastie, KJ; Reid, A1

Other Studies

1 other study(ies) available for 23-seleno-25-homotaurocholic acid and epirubicin

ArticleYear
Effect of repeated intraperitoneal chemotherapy with epirubicin on the hepatic transport of bile acids and their enterohepatic circulation.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1991, Volume: 17, Issue:1

    Topics: Animals; Bile Acids and Salts; Biological Transport; Epirubicin; Infusions, Parenteral; Intestinal Mucosa; Intestines; Liver; Male; Metabolic Clearance Rate; Rats; Rats, Inbred Strains; Selenium Radioisotopes; Taurocholic Acid

1991